2020 Quality Performance Results:
ACO# |
Measure Name |
Rate |
ACO Mean |
---|---|---|---|
ACO-13 |
Falls: Screening for Future Fall Risk |
69.52 |
84.97 |
ACO-14 |
Preventive Care and Screening: Influenza Immunization |
62.02 |
59.35 |
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
82.30 |
79.49 |
ACO-18 |
Preventive Care and Screening: Screening for Depression and Follow-up Plan |
89.83 |
90.91 |
ACO-19 |
Colorectal Cancer Screening |
52.99 |
56.41 |
ACO-20 |
Breast Cancer Screening |
63.14 |
68.09 |
ACO-42 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
77.34 |
78.45 |
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
23.80 |
14.70 |
ACO-28 |
Hypertension (HTN): Controlling High Blood Pressure |
62.67 |
72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included
in public reporting due to low sample size.The Centers for Medicare & Medicaid Services
(CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020
through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS
reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized
Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting,
given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on
these measures.
For Previous Years Financial and Quality Performance Results, please visit
data.cms.gov
Payment Rule Waivers No, our ACO does not use the SNF 3-Day Rule Waiver.